New gene therapy research at Neuroscience 2019
Live-streamed press conference offers breaking research
Credit: Society for Neuroscience
Gene therapy shows promise as a way to treat and cure presently incurable neurological diseases, including Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS). Hear leading scientists announce their new findings at Neuroscience 2019, the world’s largest source of emerging news and cutting-edge research on the brain and nervous system.
Watch a press conference on gene therapy Oct. 20, 2019, 1 p.m. CDT via live stream in our online press room or attend the conference in Chicago. Credentialed media receive complimentary registration to Neuroscience 2019 and access to online and on-site press rooms, top neuroscientists, embargoed press materials, and special events, providing a rich collection of news and feature possibilities.
Register for Neuroscience 2019 here and visit our online press room.
Gene Therapy: Curing the Incurable
Sunday, October 20, 1 p.m. – 2 p.m. CDT
Gene therapy shows promise as a way to prevent, treat, and reverse neurological disorders that are presently incurable, such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS). Gene therapy is a cutting-edge technique that uses viruses to alter the genetic code of cells, including repairing a mutated gene, silencing a disease-causing gene, or inserting a disease-fighting gene. Researchers will discuss successes in using gene therapy to restore lost functions in animal models of neurological diseases, as well as technique advancements that may improve future treatments.
About the Society for Neuroscience
The Society for Neuroscience is the world’s largest organization of scientists and physicians devoted to understanding the brain and nervous system. The nonprofit organization, founded in 1969, now has nearly 37,000 members in more than 90 countries and over 130 chapters worldwide.